FDA Inspection 1046565 — Pacific BioLabs, Inc.

Pacific BioLabs, Inc. — FEI 2914117

The FDA completed an inspection of Pacific BioLabs, Inc. on Mar 19, 2018 in Hercules, CA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 4 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Mar 19, 2018
Fiscal Year
2018
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Hercules, CA (United States)

Citations

IDCFRDescription
110521 CFR 211.22(d)Procedures not in writing, fully followed
181021 CFR 211.160(a)Lab controls established, including changes
435321 CFR 211.160(b)(4)Instruments, apparatus, et. al. not meeting specs
440221 CFR 211.192Written record of investigation incomplete

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.